This research report provides a comprehensive analysis of the Viral Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Viral Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Viral Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Viral Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Viral Vaccines market presents opportunities for various stakeholders, including Hospital, Pharmaceutical Factory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Viral Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Viral Vaccines market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Viral Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Viral Vaccines market.
Market Overview: The report provides a comprehensive overview of the Viral Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Attenuated Vaccine, Inactivated Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Viral Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Viral Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Viral Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Viral Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Viral Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Viral Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Viral Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Viral Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Viral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Attenuated Vaccine
Inactivated Vaccine
Market segment by Application
Hospital
Pharmaceutical Factory
Research Institute
Others
Global Viral Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vaccines, market overview.
Chapter 2: Global Viral Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Viral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Viral Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vaccines Overall Market Size
2.1 Global Viral Vaccines Market Size: 2023 VS 2030
2.2 Global Viral Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Viral Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Viral Vaccines Players in Global Market
3.2 Top Global Viral Vaccines Companies Ranked by Revenue
3.3 Global Viral Vaccines Revenue by Companies
3.4 Global Viral Vaccines Sales by Companies
3.5 Global Viral Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Viral Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Viral Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viral Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Viral Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Viral Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vaccines Market Size Markets, 2023 & 2030
4.1.2 Attenuated Vaccine
4.1.3 Inactivated Vaccine
4.2 By Type - Global Viral Vaccines Revenue & Forecasts
4.2.1 By Type - Global Viral Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Viral Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Viral Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Viral Vaccines Sales & Forecasts
4.3.1 By Type - Global Viral Vaccines Sales, 2019-2024
4.3.2 By Type - Global Viral Vaccines Sales, 2025-2030
4.3.3 By Type - Global Viral Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Viral Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vaccines Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Pharmaceutical Factory
5.1.4 Research Institute
5.1.5 Others
5.2 By Application - Global Viral Vaccines Revenue & Forecasts
5.2.1 By Application - Global Viral Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Viral Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Viral Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Viral Vaccines Sales & Forecasts
5.3.1 By Application - Global Viral Vaccines Sales, 2019-2024
5.3.2 By Application - Global Viral Vaccines Sales, 2025-2030
5.3.3 By Application - Global Viral Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Viral Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Viral Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Viral Vaccines Revenue & Forecasts
6.2.1 By Region - Global Viral Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Viral Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Viral Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Viral Vaccines Sales & Forecasts
6.3.1 By Region - Global Viral Vaccines Sales, 2019-2024
6.3.2 By Region - Global Viral Vaccines Sales, 2025-2030
6.3.3 By Region - Global Viral Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Viral Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Viral Vaccines Sales, 2019-2030
6.4.3 US Viral Vaccines Market Size, 2019-2030
6.4.4 Canada Viral Vaccines Market Size, 2019-2030
6.4.5 Mexico Viral Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Viral Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Viral Vaccines Sales, 2019-2030
6.5.3 Germany Viral Vaccines Market Size, 2019-2030
6.5.4 France Viral Vaccines Market Size, 2019-2030
6.5.5 U.K. Viral Vaccines Market Size, 2019-2030
6.5.6 Italy Viral Vaccines Market Size, 2019-2030
6.5.7 Russia Viral Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Viral Vaccines Market Size, 2019-2030
6.5.9 Benelux Viral Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Viral Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Viral Vaccines Sales, 2019-2030
6.6.3 China Viral Vaccines Market Size, 2019-2030
6.6.4 Japan Viral Vaccines Market Size, 2019-2030
6.6.5 South Korea Viral Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Viral Vaccines Market Size, 2019-2030
6.6.7 India Viral Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Viral Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Viral Vaccines Sales, 2019-2030
6.7.3 Brazil Viral Vaccines Market Size, 2019-2030
6.7.4 Argentina Viral Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Viral Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Viral Vaccines Sales, 2019-2030
6.8.3 Turkey Viral Vaccines Market Size, 2019-2030
6.8.4 Israel Viral Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Viral Vaccines Market Size, 2019-2030
6.8.6 UAE Viral Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Viral Vaccines Major Product Offerings
7.1.4 GSK Viral Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Viral Vaccines Major Product Offerings
7.2.4 Merck Viral Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Viral Vaccines Major Product Offerings
7.3.4 Novartis Viral Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Viral Vaccines Major Product Offerings
7.4.4 Pfizer Viral Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Viral Vaccines Major Product Offerings
7.5.4 Sanofi Viral Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Viral Vaccines Major Product Offerings
7.6.4 Bayer Viral Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Bayer Key News & Latest Developments
7.7 Zoetis
7.7.1 Zoetis Company Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Viral Vaccines Major Product Offerings
7.7.4 Zoetis Viral Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Zoetis Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Viral Vaccines Major Product Offerings
7.8.4 AstraZeneca Viral Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Johnson
7.9.1 Johnson Company Summary
7.9.2 Johnson Business Overview
7.9.3 Johnson Viral Vaccines Major Product Offerings
7.9.4 Johnson Viral Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Johnson Key News & Latest Developments
7.10 CSL
7.10.1 CSL Company Summary
7.10.2 CSL Business Overview
7.10.3 CSL Viral Vaccines Major Product Offerings
7.10.4 CSL Viral Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 CSL Key News & Latest Developments
8 Global Viral Vaccines Production Capacity, Analysis
8.1 Global Viral Vaccines Production Capacity, 2019-2030
8.2 Viral Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Viral Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Viral Vaccines Supply Chain Analysis
10.1 Viral Vaccines Industry Value Chain
10.2 Viral Vaccines Upstream Market
10.3 Viral Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Viral Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Viral Vaccines in Global Market
Table 2. Top Viral Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Viral Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Viral Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Viral Vaccines Sales by Companies, (K MT), 2019-2024
Table 6. Global Viral Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Viral Vaccines Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Viral Vaccines Product Type
Table 9. List of Global Tier 1 Viral Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Viral Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Viral Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Viral Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Viral Vaccines Sales (K MT), 2019-2024
Table 15. By Type - Global Viral Vaccines Sales (K MT), 2025-2030
Table 16. By Application ? Global Viral Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Viral Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Viral Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Viral Vaccines Sales (K MT), 2019-2024
Table 20. By Application - Global Viral Vaccines Sales (K MT), 2025-2030
Table 21. By Region ? Global Viral Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Viral Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Viral Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Viral Vaccines Sales (K MT), 2019-2024
Table 25. By Region - Global Viral Vaccines Sales (K MT), 2025-2030
Table 26. By Country - North America Viral Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Viral Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Viral Vaccines Sales, (K MT), 2019-2024
Table 29. By Country - North America Viral Vaccines Sales, (K MT), 2025-2030
Table 30. By Country - Europe Viral Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Viral Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Viral Vaccines Sales, (K MT), 2019-2024
Table 33. By Country - Europe Viral Vaccines Sales, (K MT), 2025-2030
Table 34. By Region - Asia Viral Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Viral Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Viral Vaccines Sales, (K MT), 2019-2024
Table 37. By Region - Asia Viral Vaccines Sales, (K MT), 2025-2030
Table 38. By Country - South America Viral Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Viral Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Viral Vaccines Sales, (K MT), 2019-2024
Table 41. By Country - South America Viral Vaccines Sales, (K MT), 2025-2030
Table 42. By Country - Middle East & Africa Viral Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Viral Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Viral Vaccines Sales, (K MT), 2019-2024
Table 45. By Country - Middle East & Africa Viral Vaccines Sales, (K MT), 2025-2030
Table 46. GSK Company Summary
Table 47. GSK Viral Vaccines Product Offerings
Table 48. GSK Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. GSK Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Viral Vaccines Product Offerings
Table 52. Merck Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. Merck Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Viral Vaccines Product Offerings
Table 56. Novartis Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. Novartis Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Viral Vaccines Product Offerings
Table 60. Pfizer Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Viral Vaccines Product Offerings
Table 64. Sanofi Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Viral Vaccines Product Offerings
Table 68. Bayer Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. Bayer Key News & Latest Developments
Table 70. Zoetis Company Summary
Table 71. Zoetis Viral Vaccines Product Offerings
Table 72. Zoetis Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. Zoetis Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Viral Vaccines Product Offerings
Table 76. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Johnson Company Summary
Table 79. Johnson Viral Vaccines Product Offerings
Table 80. Johnson Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. Johnson Key News & Latest Developments
Table 82. CSL Company Summary
Table 83. CSL Viral Vaccines Product Offerings
Table 84. CSL Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. CSL Key News & Latest Developments
Table 86. Viral Vaccines Production Capacity (K MT) of Key Manufacturers in Global Market, 2022-2024 (K MT)
Table 87. Global Viral Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Viral Vaccines Production by Region, 2019-2024 (K MT)
Table 89. Global Viral Vaccines Production by Region, 2025-2030 (K MT)
Table 90. Viral Vaccines Market Opportunities & Trends in Global Market
Table 91. Viral Vaccines Market Drivers in Global Market
Table 92. Viral Vaccines Market Restraints in Global Market
Table 93. Viral Vaccines Raw Materials
Table 94. Viral Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Viral Vaccines Downstream
Table 96. Viral Vaccines Downstream Clients in Global Market
Table 97. Viral Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Viral Vaccines Segment by Type in 2023
Figure 2. Viral Vaccines Segment by Application in 2023
Figure 3. Global Viral Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Viral Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Viral Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Viral Vaccines Sales in Global Market: 2019-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Viral Vaccines Revenue in 2023
Figure 9. By Type - Global Viral Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Viral Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Viral Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Viral Vaccines Price (USD/MT), 2019-2030
Figure 13. By Application - Global Viral Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Viral Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Viral Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Viral Vaccines Price (USD/MT), 2019-2030
Figure 17. By Region - Global Viral Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Viral Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Viral Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Viral Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Viral Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Viral Vaccines Sales Market Share, 2019-2030
Figure 23. US Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Viral Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Viral Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Viral Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Viral Vaccines Sales Market Share, 2019-2030
Figure 37. China Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Viral Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Viral Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Viral Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Viral Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Viral Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Viral Vaccines Production Capacity (K MT), 2019-2030
Figure 53. The Percentage of Production Viral Vaccines by Region, 2023 VS 2030
Figure 54. Viral Vaccines Industry Value Chain
Figure 55. Marketing Channels
